Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - NOVAVAX INC | v431853_ex32-2.htm |
| EX-10.10 - EXHIBIT 10.10 - NOVAVAX INC | v431853_ex10-10.htm |
| EX-31.1 - EXHIBIT 31.1 - NOVAVAX INC | v431853_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - NOVAVAX INC | v431853_ex31-2.htm |
| EX-21 - EXHIBIT 21 - NOVAVAX INC | v431853_ex21.htm |
| EX-32.1 - EXHIBIT 32.1 - NOVAVAX INC | v431853_ex32-1.htm |
| EX-10.51 - EXHIBIT 10.51 - NOVAVAX INC | v431853_ex10-51.htm |
| EX-10.52 - EXHIBIT 10.52 - NOVAVAX INC | v431853_ex10-52.htm |
| EX-23.1 - EXHIBIT 23.1 - NOVAVAX INC | v431853_ex23-1.htm |
| 10-K - FORM 10-K - NOVAVAX INC | v431853_10k.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 12, 2014 with respect to the consolidated financial statements for the year ended December 31, 2013 included in the Annual Report of Novavax, Inc. on Form 10-K for the year ended December 31, 2015. We hereby consent to the incorporation by reference of said report in the Registration Statements of Novavax, Inc. on Forms S-3 (No. 333-193549 and No. 333-187267) and on Forms S-8 (No. 333-206354, No. 333-198121, No. 333-190600, No. 333-190599, No. 333-183113, No. 333-145298, No. 333-130990, No. 333-110401, No. 333-97931, No. 333-46000, No. 333-77611, No. 33-80279, and No. 33-80277).
/s/ Grant Thornton LLP
McLean, Virginia
February 29, 2016